Caldesmon 1 (CALD1) (C-Term) Peptide
Quick Overview for Caldesmon 1 (CALD1) (C-Term) Peptide (ABIN5672861)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- ETAGLKVGVS SRINEWLTKT PDGNKSPAPK PSDLRPGDVS SKRNLWEKQS
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- CALD1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Caldesmon (CALD1) (Caldesmon 1 (CALD1))
-
Background
-
This gene encodes a calmodulin- and actin-binding protein that plays an essential role in the regulation of smooth muscle and nonmuscle contraction. The conserved domain of this protein possesses the binding activities to Ca(2+)-calmodulin, actin, tropomyosin, myosin, and phospholipids. This protein is a potent inhibitor of the actin-tropomyosin activated myosin MgATPase, and serves as a mediating factor for Ca(2+)-dependent inhibition of smooth muscle contraction. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms.
Alias Symbols: CDM, HCAD, LCAD, H-CAD, L-CAD, NAG22
Protein Size: 532 -
Gene ID
- 800
-
NCBI Accession
- NM_004342, NP_004333
Target
-